French Health Spend Moderates After Rise

13 November 1997

The rise in French health spending tracked over six months slowed inSeptember, rising only 0.1%, say data published by the CNAM health fund organization. Rises in August and July were 0.3% and 0.2% respectively. Drug spending also eased in September, after rising 1.1% in August and 1.3% in July.

- The World Federation of Advertisers has attacked an amendment in France's 1998 Finance Bill which imposes a 1% tax on free catalogs, prospectuses, direct mail and newspaper published for a specific brand or company. The WFA says this could threaten economic growth and therefore jobs, and seriously curtail advertisers' communication capability.

Subsidizing one medium by levying a tax on its competitors is "unhealthy and opportune," it says, and warns that although the tax proposed is only 1%, this "does not preclude the temptation....to raise this level further during the coming years."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight